Acorah Software Products - Accounts Production 18.1.200 false true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 12568155 Mr S Lewis Mr T Mcdonald Mr I Jarry iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12568155 2024-12-31 12568155 2025-12-31 12568155 2025-01-01 2025-12-31 12568155 frs-core:CurrentFinancialInstruments 2025-12-31 12568155 frs-core:ComputerEquipment 2025-01-01 2025-12-31 12568155 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 12568155 frs-core:FurnitureFittings 2025-01-01 2025-12-31 12568155 frs-core:OtherResidualIntangibleAssets 2025-12-31 12568155 frs-core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 12568155 frs-core:OtherResidualIntangibleAssets 2024-12-31 12568155 frs-core:PlantMachinery 2025-12-31 12568155 frs-core:PlantMachinery 2025-01-01 2025-12-31 12568155 frs-core:PlantMachinery 2024-12-31 12568155 frs-core:OtherReservesSubtotal 2025-12-31 12568155 frs-core:SharePremium 2025-12-31 12568155 frs-core:ShareCapital 2025-12-31 12568155 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 12568155 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 12568155 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 12568155 frs-bus:SmallEntities 2025-01-01 2025-12-31 12568155 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 12568155 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 12568155 frs-bus:OrdinaryShareClass1 2025-01-01 2025-12-31 12568155 frs-bus:OrdinaryShareClass1 2025-12-31 12568155 frs-bus:OrdinaryShareClass3 2025-01-01 2025-12-31 12568155 frs-bus:OrdinaryShareClass3 2025-12-31 12568155 frs-bus:Director1 2025-01-01 2025-12-31 12568155 frs-bus:Director2 2025-01-01 2025-12-31 12568155 frs-bus:Director3 2025-01-01 2025-12-31 12568155 frs-countries:EnglandWales 2025-01-01 2025-12-31 12568155 2023-12-31 12568155 2024-12-31 12568155 2024-01-01 2024-12-31 12568155 frs-core:CurrentFinancialInstruments 2024-12-31 12568155 frs-core:OtherReservesSubtotal 2024-12-31 12568155 frs-core:SharePremium 2024-12-31 12568155 frs-core:ShareCapital 2024-12-31 12568155 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 12568155 frs-bus:OrdinaryShareClass1 2024-01-01 2024-12-31 12568155 frs-bus:OrdinaryShareClass3 2024-01-01 2024-12-31
Registered number: 12568155
Clerkenwell Clinics Limited
Unaudited Financial Statements
For The Year Ended 31 December 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 12568155
2025 2024
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 - 30,387
Tangible Assets 5 470,701 250,014
470,701 280,401
CURRENT ASSETS
Work in progress 6 235,261 42,024
Debtors 7 831,892 539,816
Cash at bank and in hand 349,648 206,919
1,416,801 788,759
Creditors: Amounts Falling Due Within One Year 8 (1,870,551 ) (950,105 )
NET CURRENT ASSETS (LIABILITIES) (453,750 ) (161,346 )
TOTAL ASSETS LESS CURRENT LIABILITIES 16,951 119,055
NET ASSETS 16,951 119,055
CAPITAL AND RESERVES
Called up share capital 9 110 98
Share premium account 5,800,409 4,317,226
Other reserves 475,000 -
Profit and Loss Account (6,258,568 ) (4,198,269 )
SHAREHOLDERS' FUNDS 16,951 119,055
Page 1
Page 2
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr S Lewis
Director
16th April 2026
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Clerkenwell Clinics Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12568155 . The registered office is 39 Welbeck Stree, London, W1G 8DR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are software development costs. This asset has been amortised over its estimated economic life of 10 years to the profit and loss account. During the current year development of the software was halted and as a result the asset has been deemed to have no further economic value and this has been impaired to £nil. 
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% on cost
Fixtures & Fittings 25% on cost
Computer Equipment 25% on cost
2.5. Leasing and Hire Purchase Contracts
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
2.6. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
Page 3
Page 4
2.7. Financial Instruments
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Short term creditors are measured at the transaction price. Other financial liabilities,  including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors, creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method.
Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements or a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.
2.8. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.9. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
2.10. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 43 (2024: 32)
43 32
Page 4
Page 5
4. Intangible Assets
Other
£
Cost
As at 1 January 2025 42,820
As at 31 December 2025 42,820
Amortisation
As at 1 January 2025 12,433
Provided during the period 4,282
Impairment losses 26,105
As at 31 December 2025 42,820
Net Book Value
As at 31 December 2025 -
As at 1 January 2025 30,387
5. Tangible Assets
Plant & Machinery etc.
£
Cost
As at 1 January 2025 367,639
Additions 336,090
Disposals (9,039 )
As at 31 December 2025 694,690
Depreciation
As at 1 January 2025 117,625
Provided during the period 111,721
Disposals (5,357 )
As at 31 December 2025 223,989
Net Book Value
As at 31 December 2025 470,701
As at 1 January 2025 250,014
6. Work in progress
2025 2024
£ £
Work in progress 235,261 42,024
Page 5
Page 6
7. Debtors
2025 2024
£ £
Due within one year
Trade debtors 506,125 382,659
Other debtors 325,767 157,157
831,892 539,816
8. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 1,209,793 132,457
Other creditors 457,293 730,197
Taxation and social security 203,465 87,451
1,870,551 950,105
9. Share Capital
2025 2024
Allotted, called up and fully paid £ £
721,829 Ordinary Shares of £ 0.0001 each 72 69
383,965 SEED shares of £ 0.0001 each 38 29
110 98
Page 6